Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Jesús Álvarez-García Added: 7 months ago
ESC 23 — Dr Jesus Alvarez-Garcia (Ramon and Cajal University Hospital, ES) considers the use of ReDS technology in patients with acute heart failure (ReDS-SAFE HF) (NCT04305717) in this short interview. The ReDS-SAFE HF study (Icahn School of Medicine at Mount Sinai) aimed to test the remote dielectric sensing (ReDS) system, a novel electromagnetic technology that can noninvasively quantify… View more
Author(s): Christian Veltmann Added: 3 years ago
ProfVeltmann (Hannover, GER) presents evidence on the topic of current treatement strategies for newly diagnosed heart failure patients and the benefit of prolonged WCD wear time. View more
Author(s): Marco Schiavone Added: 2 years ago
In this short interview recorded at EHRA 2022, Dr Marco Schiavone (Luigi Sacco University Hospital, Milan, IT) outlines the findings of a real-world meta-analysis designed to assess the clinical outcomes of S-ICD in HF patients from the largest European Registry. Results suggest that over 2 years, there were no significant differences in appropriate and inappropriate shocks between patients with… View more
Start date: May 21, 2023 End date: May 21, 2023
Radcliffe Medical Education is hosting a symposium entitled 'Overcoming the Challenges in Optimising GDMT in Heart Failure' at theHeart Failure Association (HFA)in Prague, CZ, on Sunday 21 May 2023 at 12:30 - 13:30 CEST. Add to your calendar. Overview In this symposium we join Dr Gianluigi Savarese (Karolinska Institute, Stockholm, SE), Dr Stephen Greene (Duke University School of Medicine,… View more
Author(s): Mark M Boogers , Frank M Bengel , Juhani Knuuti , et al Added: 3 years ago
Chronic heart failure (HF) is an important healthcare problem in the developed world, since incidence and prevalence numbers have increased rapidly over recent decades. Recently, the American Heart Association (AHA) Statistics Committee and Stroke Statistics Committee reported that chronic HF affects 5.3 million patients in the US, with approximately 660,000 newly diagnosed patients each year.1… View more
Author(s): Andrea Mortara Added: 3 years ago
Data from Italian, European and US registries clearly show that a large proportion of acute hospitalisations for heart failure (HF) could be avoided by improving the follow-up of patients at home after discharge.1–3 There are many factors that may contribute to decompensation, including reduced coronary perfusion, anaemia, hypertension, infections, arrhythmias and renal failure. The important… View more
Author(s): Antoni Bayés-Genís Added: 3 years ago
The long-awaited 2016 European Society of Cardiology (ESC) guidelines for heart failure (HF)1 provide the large amount of novel research in HF since the previous guidelines published in 2012.2 Here, highlights of the 2016 guidelines are presented. Definition of Heart Failure The main terminology used to describe HF is historically based on measurement of the left ventricular ejection fraction … View more
Author(s): Martin Moeckel Added: 4 years ago
Prof Martin Mockel (Charité University, Berlin, DE) discusses biomarker guidance to start remote patient management in heart failure. Filmed on site at HFA 2019 by Radcliffe Cardiology. Videography: Mike Knight & Tom Green Interviewer: Liam O'Neill View more
Author(s): Christian Sohns , Philipp Sommer Added: 7 months ago
ESC 2023 — We are joined onsite by Prof Christian Sohns and Prof Philipp Sommer (Heart and Diabetes Centre, Bad Oyenhausen, DE) to discuss the findings from the CASTLE-HTx trial (NCT04649801). CASTLE-HTx (Heart and Diabetes Center North-Rhine Westfalia) aimed to determine if atrial fibrillation ablation has beneficial effects on mortality in patients with end-stage heart failure, who are… View more
Author(s): Kana Shimizu , Masafumi Funamoto , Mai Genpei , et al Added: 3 years ago
Topic: 3. Heart Failure and Cardiomyopathy Introduction and Objectives Signals activated by increased hemodynamic overload to the heart finally reach the nuclei of cardiac myocytes and induce maladaptive hypertrophy in them. Nuclear acetylation, which is controlled by histone deacetylases and the intrinsic histone acetyltransferase p300, is a critical event in this process. We previously… View more